KOREA WHO
-
-
-
Chairman of Celltrion
Seo Jung-jin
Stepped Down from Management, Returned as Chairman of the Board: Aiming to Become a Global Pharma Giant through the Merger of Three Companies
-
Last Updated on Sep 27, 2024
-
Chairman of Celltrion
Life Summary
Seo Jung-jin is the Chairman of Celltrion Group.
He is the largest shareholder of Celltrion Holdings, the holding company of Celltrion.
Although he stepped down from management claiming to establish a professional management system within Celltrion Group, he announced his return to management in March 2023 and took the position of Chairman of the Board.
He was born on October 23, 1957, in Cheongju, Chungcheongbuk-do.
Seo graduated from Jemulpo High School in Incheon and earned a degree in Industrial Engineering from Konkuk University. He also obtained a master’s degree in Business Administration from the graduate school of Konkuk University.
His career started at Samsung Electro-Mechanics. He then moved to the Korea Productivity Center, where he consulted for Daewoo Motors. His work caught the attention of Kim Woo-choong, the former chairman of Daewoo Group, and Seo worked as an advisor for Daewoo Motors' planning and finance department.
After losing his job during the Asian financial crisis, Seo co-founded Nexol, the predecessor of Celltrion, with about ten former Daewoo Motors colleagues.
Through Celltrion Healthcare, a company established to sell biosimilars overseas, he has been targeting the global market.
When COVID-19 spread worldwide, Seo developed treatments and diagnostic kits for the virus.
After stepping down from the frontlines of management in 2020, he ventured into the healthcare industry related to blood tests.
Seo is known for his keen ability to grasp key issues and his energetic nature. When things don't go as planned, he visits the site in person to find clues for solving problems.
His passion for work is so great that he considers overseas business trips a hobby.
#SeoJungjin #Celltrion #KoreanBusiness #biosimilars #COVID19 #Koreanentrepreneur #DaewooMotors #SamsungElectroMechanics #healthcare #biotech
He is the largest shareholder of Celltrion Holdings, the holding company of Celltrion.
Although he stepped down from management claiming to establish a professional management system within Celltrion Group, he announced his return to management in March 2023 and took the position of Chairman of the Board.
He was born on October 23, 1957, in Cheongju, Chungcheongbuk-do.
Seo graduated from Jemulpo High School in Incheon and earned a degree in Industrial Engineering from Konkuk University. He also obtained a master’s degree in Business Administration from the graduate school of Konkuk University.
His career started at Samsung Electro-Mechanics. He then moved to the Korea Productivity Center, where he consulted for Daewoo Motors. His work caught the attention of Kim Woo-choong, the former chairman of Daewoo Group, and Seo worked as an advisor for Daewoo Motors' planning and finance department.
After losing his job during the Asian financial crisis, Seo co-founded Nexol, the predecessor of Celltrion, with about ten former Daewoo Motors colleagues.
Through Celltrion Healthcare, a company established to sell biosimilars overseas, he has been targeting the global market.
When COVID-19 spread worldwide, Seo developed treatments and diagnostic kits for the virus.
After stepping down from the frontlines of management in 2020, he ventured into the healthcare industry related to blood tests.
Seo is known for his keen ability to grasp key issues and his energetic nature. When things don't go as planned, he visits the site in person to find clues for solving problems.
His passion for work is so great that he considers overseas business trips a hobby.
#SeoJungjin #Celltrion #KoreanBusiness #biosimilars #COVID19 #Koreanentrepreneur #DaewooMotors #SamsungElectroMechanics #healthcare #biotech